Credit Acceptance Corp trust files to offload 40,000 shares worth $20.6M

Rhea-AI Filing Summary

Credit Acceptance Corp. (CACC) Form 144 filing: The Jill Foss Watson Living Trust intends to sell up to 40,000 common shares through UBS Securities on or after 29 Jul 2025. Based on the stated aggregate market value of $20.65 million, the implied price is about $516 per share. The planned sale equals roughly 0.34 % of CACC’s 11.60 million shares outstanding.

The trust acquired the shares in 2011 via a GRAT remainder transfer. During the past three months it already sold 20,000 shares (2 Jul 2025) for $15.87 million. The signatory affirms no undisclosed adverse information exists.

• Class: Common stock
• Broker: UBS Securities LLC, NYC
• Planned exchange: NASDAQ

The notice does not alter corporate fundamentals but signals ongoing insider liquidity activity that investors may monitor for sentiment clues.

Positive

• Transparent compliance with Rule 144 and affirmation of no undisclosed adverse information.
• Sale size is modest, representing only ~0.34 % of shares outstanding, limiting dilution/overhang risk.

Negative

• Continued insider selling (60k shares within a month) can be viewed as a bearish signal on near-term prospects.
• Potential supply overhang of $20.7 m worth of stock may pressure short-term trading sentiment.

Insights

Securities Analyst

TL;DR Insider trust plans 40k-share sale (~$20.7 m); modest 0.34 % of float, but follows recent 20k-share sale—sentiment mildly negative.

The filing reveals continued disposition by the Jill Foss Watson Living Trust. While the absolute stake is small relative to CACC’s float, cumulative 60k shares in one month (~0.5 %) may raise questions on insider outlook. Rule 144 sales are routine, yet timing near prior sale could pressure near-term trading and signal limited upside conviction.
No operational data is provided, so financial impact is limited to potential supply overhang. Investors typically discount one-off liquidity events; repeated sales warrant closer monitoring.

Corporate Governance Expert

TL;DR Routine Rule 144 filing; compliance intact, disclosure transparent—impact neutral barring market perception of insider intent.

The trust follows proper Rule 144 disclosure, naming broker, share count, and acquisition history. Affirmation of no undisclosed MNPI reduces legal risk. Governance view: transaction appears planned (possibly under 10b5-1) and does not, in itself, suggest governance weakness. Market may interpret serial sales negatively, but from a compliance standpoint the company maintains best practices.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Securities LLC 1285 Avenue of the Americas New York NY 10019	40000	20652400	11603475	07/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2011	GRAT Remainder	Founders Shares			40000	09/11/2011	GRAT Remainder

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jill Foss Watson Living Trust c/o UBS Financial Services 2000 Ave of the Stars Los Angeles CA 90067	Common	07/02/2025	20000	15874245

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many CACC shares are being sold under this Form 144?

The trust plans to sell 40,000 common shares.

What is the aggregate market value of the planned CACC sale?

The filing lists an aggregate market value of $20.65 million.

What percentage of Credit Acceptance Corp’s float does 40,000 shares represent?

Approximately 0.34 % of the 11.60 million shares outstanding.

When is the earliest sale date for the CACC shares?

The notice specifies 29 July 2025 as the approximate sale date.

Has the filer sold CACC shares recently?

Yes. The same trust sold 20,000 shares on 2 Jul 2025 for $15.87 million.

Who is acting as broker for the transaction?

The shares will be sold through UBS Securities LLC, New York on NASDAQ.